TGFB1 and lung adenocarcinoma: To examine whether sorafenib could impair TGF-β-induced EMT in epithelial cells, we used human A549 epithelial cells, a lung adenocarcinoma cell line that has been extensively used and is an ideal in vitro model for assessing EMT, carcinogenesis and drug metabolism [14].